Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!
about
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
P2860
Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Potencies of newer fluoroquino ...... (1997 to 1999): beyond Canada!
@en
Potencies of newer fluoroquino ...... microbial Surveillance Program
@nl
type
label
Potencies of newer fluoroquino ...... (1997 to 1999): beyond Canada!
@en
Potencies of newer fluoroquino ...... microbial Surveillance Program
@nl
prefLabel
Potencies of newer fluoroquino ...... (1997 to 1999): beyond Canada!
@en
Potencies of newer fluoroquino ...... microbial Surveillance Program
@nl
P2860
P1476
Potencies of newer fluoroquino ...... (1997 to 1999): beyond Canada!
@en
P2093
P2860
P304
P356
10.1128/AAC.44.10.2922-2923.2000
P407
P577
2000-10-01T00:00:00Z